Necuparanib, a Multi-Targeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Stromal Heparan Sulfate Differentiates Neuroblasts to Suppress Neuroblastoma Growth

Journal of Clinical Investigation
Medicine
2014English

Alterations of Heparan Sulfate Proteoglycans in Cancer

Journal of Glycobiology
2015English

Tumor Attenuation by Combined Heparan Sulfate and Polyamine Depletion

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Structural Analysis of Heparan Sulfate and Heparan Sulfate Oligosaccharides.

Trends in Glycoscience and Glycotechnology
BiochemistryOrganic Chemistry
1998English

Tissue-Specificity of Heparan Sulfate Biosynthetic Machinery in Cancer

Cell Adhesion and Migration
Molecular NeuroscienceCell BiologyCellular
2015English

Targeting Tumor–stromal Interactions in Bone Metastasis

Pharmacology and Therapeutics
Pharmacology
2014English

miR‑381 Functions as a Tumor Suppressor by Targeting ETS1 in Pancreatic Cancer

International Journal of Molecular Medicine
MedicineGenetics
2019English

Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Gastric Gastrointestinal Stromal Tumor and Neuroendocrine Pancreatic Tumor: Always Neurofibromatosis?

Endoscopic Ultrasound
HepatologyNuclear MedicineRadiologyImagingGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy